Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases
Status:
Completed
Trial end date:
2022-06-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effectiveness of the use of the drug, containing
Vitex agnus castus extract (VAC), in patients with fibrocystic breast disease . One hundred
fifty women over 40 years old were randomized into patient (n=78) and control (n=72) groups.
The groups were similar regarding age, nulliparity, menopause and abortion status, family
history of breast cancer, alcohol consumption, and smoking. The patient group received two
pills containing 200mg of VAC daily for six months, and all participants were evaluated by
using a Visual Analogue Scale and ultrasound examination at baseline, 12th and 24th weeks.